טוען...
Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma
BACKGROUND: While there has been significant progress in outcomes for patients diagnosed with primary central nervous system (CNS) lymphoma (PCNSL), survival rates will likely plateau with the current armamentarium of agents used to treat these patients. Moreover, given that PCNSL increasingly impac...
שמור ב:
| Main Authors: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3905778/ https://ncbi.nlm.nih.gov/pubmed/24265352 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdt385 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|